Dutch Life Sciences Trend Analysis 2016
While the first semester of 2015 was a quiet period, the second half of last year saw private Dutch biotech companies raise over USD 115m worth of funding in six rounds. Indeed it proved to be the largest financing period since the first semester of 2012.
Looking for your next Biotech or Medtech partner?
Use Biotechgate to identify new leads, licensing opportunities and management details.